Literature DB >> 18495642

Social cognition in schizophrenia.

Michael F Green1, David I Leitman.   

Abstract

Social cognition in schizophrenia is a rapidly emerging area of study. Because the number and diversity of studies in this area have increased, efforts have been made to better define terms and provide organizing frameworks. A key challenge confronting the study of social cognition in schizophrenia is building bridges between clinical scientists and social neuroscientists. The articles in this theme summarize data-based studies that have attempted to build or strengthen such bridges to better understand the neural bases of social cognitive impairment in schizophrenia.

Entities:  

Mesh:

Year:  2008        PMID: 18495642      PMCID: PMC2632454          DOI: 10.1093/schbul/sbn045

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  16 in total

Review 1.  Cognitive approaches to delusions: a critical review of theories and evidence.

Authors:  P A Garety; D Freeman
Journal:  Br J Clin Psychol       Date:  1999-06

Review 2.  Persecutory delusions: a review and theoretical integration.

Authors:  R P Bentall; R Corcoran; R Howard; N Blackwood; P Kinderman
Journal:  Clin Psychol Rev       Date:  2001-11

3.  Facial affect recognition: a mediator between cognitive and social functioning in psychosis?

Authors:  Jean Addington; Huma Saeedi; Donald Addington
Journal:  Schizophr Res       Date:  2006-05-05       Impact factor: 4.939

Review 4.  The functional significance of social cognition in schizophrenia: a review.

Authors:  Shannon M Couture; David L Penn; David L Roberts
Journal:  Schizophr Bull       Date:  2006-08-17       Impact factor: 9.306

5.  Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference.

Authors:  Michael F Green; Berend Olivier; Jacqueline N Crawley; David L Penn; Steven Silverstein
Journal:  Schizophr Bull       Date:  2005-08-31       Impact factor: 9.306

6.  Biosocial pathways to functional outcome in schizophrenia.

Authors:  John Brekke; Diane D Kay; Kimmy S Lee; Michael F Green
Journal:  Schizophr Res       Date:  2005-08-30       Impact factor: 4.939

7.  The social-emotional processing stream: five core constructs and their translational potential for schizophrenia and beyond.

Authors:  Kevin N Ochsner
Journal:  Biol Psychiatry       Date:  2008-07-01       Impact factor: 13.382

8.  Social perception as a mediator of the influence of early visual processing on functional status in schizophrenia.

Authors:  Mark J Sergi; Yuri Rassovsky; Keith H Nuechterlein; Michael F Green
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

Review 9.  Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative.

Authors:  Cameron S Carter; Deanna M Barch
Journal:  Schizophr Bull       Date:  2007-07-14       Impact factor: 9.306

10.  Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities.

Authors:  Michael F Green; David L Penn; Richard Bentall; William T Carpenter; Wolfgang Gaebel; Ruben C Gur; Ann M Kring; Sohee Park; Steven M Silverstein; Robert Heinssen
Journal:  Schizophr Bull       Date:  2008-01-08       Impact factor: 9.306

View more
  54 in total

1.  Schizotypy, alexithymia, and socioemotional outcomes.

Authors:  James P Seghers; Amanda McCleery; Nancy M Docherty
Journal:  J Nerv Ment Dis       Date:  2011-02       Impact factor: 2.254

2.  Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status.

Authors:  Philip D Harvey; Martin Strassnig
Journal:  World Psychiatry       Date:  2012-06       Impact factor: 49.548

3.  Patients with schizophrenia demonstrate inconsistent preference judgments for affective and nonaffective stimuli.

Authors:  Gregory P Strauss; Benjamin M Robinson; James A Waltz; Michael J Frank; Zuzana Kasanova; Ellen S Herbener; James M Gold
Journal:  Schizophr Bull       Date:  2010-05-19       Impact factor: 9.306

Review 4.  Oxytocin and social cognition in affective and psychotic disorders.

Authors:  M Mercedes Perez-Rodriguez; Katie Mahon; Manuela Russo; Allison K Ungar; Katherine E Burdick
Journal:  Eur Neuropsychopharmacol       Date:  2014-08-01       Impact factor: 4.600

5.  Social-cognitive remediation in schizophrenia: generalization of effects of the Training of Affect Recognition (TAR).

Authors:  Wolfgang Wölwer; Nicole Frommann
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

6.  Social cognition psychometric evaluation (SCOPE) in people with early psychosis: A preliminary study.

Authors:  Kelsey A Ludwig; Amy E Pinkham; Philip D Harvey; Skylar Kelsven; David L Penn
Journal:  Schizophr Res       Date:  2017-03-14       Impact factor: 4.939

7.  Dysfunction of a cortical midline network during emotional appraisals in schizophrenia.

Authors:  Daphne J Holt; Balaji Lakshmanan; Oliver Freudenreich; Donald C Goff; Scott L Rauch; Gina R Kuperberg
Journal:  Schizophr Bull       Date:  2009-07-15       Impact factor: 9.306

8.  White Matter Abnormalities Associated With Subsyndromal Psychotic-Like Symptoms Predict Later Social Competence in Children and Adolescents.

Authors:  Pamela DeRosse; Toshikazu Ikuta; Katherine H Karlsgodt; Bart D Peters; Chaya B Gopin; Philip R Szeszko; Anil K Malhotra
Journal:  Schizophr Bull       Date:  2016-05-17       Impact factor: 9.306

9.  The 5% difference: early sensory processing predicts sarcasm perception in schizophrenia and schizo-affective disorder.

Authors:  J T Kantrowitz; M J Hoptman; D I Leitman; G Silipo; D C Javitt
Journal:  Psychol Med       Date:  2013-04-24       Impact factor: 7.723

Review 10.  What do we know about neuropsychological aspects of schizophrenia?

Authors:  Barton W Palmer; Sharron E Dawes; Robert K Heaton
Journal:  Neuropsychol Rev       Date:  2009-07-30       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.